EXT1 anticorps (AA 28-171) (FITC)
Aperçu rapide pour EXT1 anticorps (AA 28-171) (FITC) (ABIN7152307)
Antigène
Voir toutes EXT1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 28-171
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Exostosin-1 protein (28-171AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- EXT1 (Exostosin 1 (EXT1))
-
Autre désignation
- EXT1
-
Sujet
-
Background: Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413).
Aliases: 4-alpha-N-acetylglucosaminyltransferase antibody, exostoses (multiple) 1 antibody, Exostosin 1 antibody, Exostosin glycosyltransferase 1 antibody, Exostosin-1 antibody, EXT antibody, EXT1 antibody, EXT1_HUMAN antibody, Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase antibody, glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan antibody, Langer-Giedion syndrome chromosome region antibody, LGCR antibody, LGS antibody, Multiple exostoses protein 1 antibody, Multiple exostoses protein 1 homolog antibody, N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase antibody, Putative tumor suppressor protein EXT1 antibody, TRPS2 antibody, TTV antibody
-
UniProt
- Q16394
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-